RECRUITINGINTERVENTIONAL
Comparison of Self- and Balloon-expandable Valves in Patients With Ascending Aortic Dilation Undergoing Transcatheter Aortic Valve Replacement: The AAD-CHOICE
About This Trial
This study aimed at comparing the performance of self-expandable valves versus balloon-expandable valves in patients with ascending aortic dilation undergoing transcatheter aortic valve replacement.
Who May Be Eligible (Plain English)
Who May Qualify:
- Severe aortic stenosis;
- Transfemoral access;
- Preoperative aortic CT suggesting maximum ascending aortic diameter ≥45mm and \<55mm;
- Anticipated life expectancy \>1 year;
- Age ≥ 65 years.
Who Should NOT Join This Trial:
- Dominant aortic regurgitation,;
- A history of SAVR or TAVR;
- A history of aortic surgery;
- Emergent TAVR.
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Severe aortic stenosis;
* Transfemoral access;
* Preoperative aortic CT suggesting maximum ascending aortic diameter ≥45mm and \<55mm;
* Anticipated life expectancy \>1 year;
* Age ≥ 65 years.
Exclusion Criteria:
* Dominant aortic regurgitation,;
* A history of SAVR or TAVR;
* A history of aortic surgery;
* Emergent TAVR.
Treatments Being Tested
DEVICE
self-expandable valves
patients undergoing TAVR use self-expandable valves
DEVICE
balloon-expandable valves
patients undergoing TAVR use balloon-expandable valves
Locations (1)
National Center for Cardiovascular Disease, China & Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College
Beijing, Beijing Municipality, China